Rep. Jefferson Shreve Purchases Shares of Zoetis Inc. (NYSE:ZTS)

Representative Jefferson Shreve (R-Indiana) recently bought shares of Zoetis Inc. NYSE: ZTS. In a filing disclosed on April 11th, the Representative disclosed that they had bought between $15,001 and $50,000 in Zoetis stock on March 5th. The trade occurred in the Representative's "CRT - STANDARD UNIT TRUST" account.

Representative Jefferson Shreve also recently made the following trade(s):

• Purchased $15,001 - $50,000 in shares of Harley-Davidson NYSE: HOG on 3/31/2025.
• Purchased $50,001 - $100,000 in shares of Block NYSE: XYZ on 3/31/2025.
• Sold $15,001 - $50,000 in shares of DuPont de Nemours NYSE: DD on 3/31/2025.
• Purchased $15,001 - $50,000 in shares of United Community Banks NASDAQ: UCB on 3/31/2025.
• Sold $15,001 - $50,000 in shares of IDEX NYSE: IEX on 3/31/2025.
• Purchased $15,001 - $50,000 in shares of HNI NYSE: HNI on 3/31/2025.
• Sold $50,001 - $100,000 in shares of ServiceNow NYSE: NOW on 3/31/2025.
• Sold $15,001 - $50,000 in shares of Coinbase Global NASDAQ: COIN on 3/31/2025.
• Sold $15,001 - $50,000 in shares of Constellation Energy NASDAQ: CEG on 3/31/2025.
• Sold $50,001 - $100,000 in shares of Simon Property Group NYSE: SPG on 3/31/2025.

Zoetis Trading Up 1.3 %

Zoetis stock traded up $1.88 during trading on Friday, hitting $148.64. The company had a trading volume of 4,239,788 shares, compared to its average volume of 2,537,631. The company has a current ratio of 1.75, a quick ratio of 1.08 and a debt-to-equity ratio of 1.09. The company's 50 day simple moving average is $160.04 and its 200-day simple moving average is $169.80. Zoetis Inc. has a 1-year low of $139.70 and a 1-year high of $200.33. The stock has a market cap of $66.32 billion, a price-to-earnings ratio of 27.17, a price-to-earnings-growth ratio of 2.78 and a beta of 0.92.

Zoetis (NYSE:ZTS - Get Free Report) last posted its quarterly earnings data on Thursday, February 13th. The company reported $1.40 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.37 by $0.03. Zoetis had a return on equity of 53.82% and a net margin of 26.86%. The firm had revenue of $2.32 billion for the quarter, compared to the consensus estimate of $2.30 billion. As a group, analysts expect that Zoetis Inc. will post 6.07 EPS for the current fiscal year.

Zoetis Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 3rd. Stockholders of record on Monday, April 21st will be issued a $0.50 dividend. The ex-dividend date is Monday, April 21st. This represents a $2.00 annualized dividend and a dividend yield of 1.35%. Zoetis's dividend payout ratio is currently 36.56%.

Analyst Ratings Changes

A number of brokerages recently weighed in on ZTS. Piper Sandler lifted their price objective on shares of Zoetis from $200.00 to $205.00 and gave the company an "overweight" rating in a report on Thursday, February 27th. StockNews.com raised Zoetis from a "hold" rating to a "buy" rating in a research report on Friday, March 7th. Morgan Stanley decreased their target price on Zoetis from $243.00 to $238.00 and set an "overweight" rating for the company in a report on Friday, February 14th. Stifel Nicolaus cut their price target on Zoetis from $180.00 to $165.00 and set a "buy" rating on the stock in a report on Monday, April 14th. Finally, Barclays boosted their price objective on Zoetis from $242.00 to $244.00 and gave the stock an "overweight" rating in a research report on Friday, February 14th. One equities research analyst has rated the stock with a hold rating, ten have given a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of "Buy" and a consensus target price of $214.40.

Hedge Funds Weigh In On Zoetis

Several large investors have recently bought and sold shares of the stock. Howard Capital Management Group LLC lifted its stake in Zoetis by 0.8% in the third quarter. Howard Capital Management Group LLC now owns 104,866 shares of the company's stock valued at $20,489,000 after buying an additional 883 shares during the last quarter. Principal Financial Group Inc. increased its stake in Zoetis by 17.3% in the third quarter. Principal Financial Group Inc. now owns 2,377,403 shares of the company's stock valued at $464,497,000 after purchasing an additional 351,372 shares during the period. Toronto Dominion Bank raised its holdings in shares of Zoetis by 18.8% in the third quarter. Toronto Dominion Bank now owns 233,486 shares of the company's stock valued at $45,618,000 after buying an additional 37,013 shares during the last quarter. TD Private Client Wealth LLC grew its holdings in shares of Zoetis by 10.5% during the third quarter. TD Private Client Wealth LLC now owns 11,640 shares of the company's stock worth $2,274,000 after buying an additional 1,106 shares during the last quarter. Finally, Diamant Asset Management Inc. increased its position in Zoetis by 2.4% in the 3rd quarter. Diamant Asset Management Inc. now owns 4,465 shares of the company's stock valued at $872,000 after acquiring an additional 105 shares during the period. Institutional investors and hedge funds own 92.80% of the company's stock.

Insider Buying and Selling at Zoetis

In other news, Director Willie M. Reed sold 1,210 shares of the company's stock in a transaction that occurred on Tuesday, March 11th. The stock was sold at an average price of $166.14, for a total transaction of $201,029.40. Following the completion of the sale, the director now owns 11,245 shares in the company, valued at $1,868,244.30. This represents a 9.71 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, EVP Roxanne Lagano sold 326 shares of Zoetis stock in a transaction on Monday, March 10th. The shares were sold at an average price of $170.00, for a total transaction of $55,420.00. Following the completion of the transaction, the executive vice president now owns 15,781 shares in the company, valued at approximately $2,682,770. This trade represents a 2.02 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 1,862 shares of company stock valued at $312,254 in the last ninety days. Insiders own 0.16% of the company's stock.

About Representative Shreve

Jefferson Shreve (Republican Party) is a member of the U.S. House, representing Indiana's 6th Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027. Shreve (Republican Party) is running for re-election to the U.S. House to represent Indiana's 6th Congressional District. He declared candidacy for the 2026 election. Email editor@ballotpedia.org to notify us of updates to this biography. Jefferson Shreve earned a bachelor's degree from Indiana University in 1989, a graduate degree from the University of London in 1998, and a graduate degree from Purdue University in 2003. Shreve's career experience includes working as a real estate executive. Shreve was elected 7th District Vice Chairman of the Indiana Republican State Committee on January 17, 2018, and was re-elected on March 6, 2021. In 2020, he was selected as a district-level delegate to the 2020 Republican National Convention.

About Zoetis

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.